Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002526384 | SCV000541647 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-05-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411425 | SCV002675810 | uncertain significance | Cardiovascular phenotype | 2024-04-25 | criteria provided, single submitter | clinical testing | The p.R2806C variant (also known as c.8416C>T), located in coding exon 56 of the RYR2 gene, results from a C to T substitution at nucleotide position 8416. The arginine at codon 2806 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002480340 | SCV002783679 | uncertain significance | Arrhythmogenic right ventricular dysplasia 2; Catecholaminergic polymorphic ventricular tachycardia 1; Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | 2021-07-02 | criteria provided, single submitter | clinical testing |